News
Manel Esteller and Jaume Reventós new members of the Institute of Catalan Studies
The Plenum of the Institute of Catalan Studies (IEC) has announced the addition of five new members. at the Biological Sciences section: Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Institute of Biomedical Research of Bellvitge (IDIBELL); Bonaventura Clotet, head of the HIV Unit of the University Hospital Germans Trias i […]
Ten students will live the summer in IDIBELL
The scientific direction of IDIBELL has published the resolution of the 2015 summer internship. Ten students will practice in IDIBELL research groups during the months of July, August and September. They are young people who have completed this course university studies in the field of biomedicine. Here you can check the resolution We congratulate the […]
IDIBELL and the Universidad Autónoma de Nueva León sign a collaboration agreement
On June 17 the hall of the Ministry of Health Department of the Generalitat of Catalonia hosted the signing of the cooperation agreement between the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Universidad Autónoma de Nueva León (UANL), Monterrey, Mexico. The event was attended by the Director General of Health Planning and Research […]
Researchers find a potential target for the treatment of type 2 diabetes
Deletion of S6K1 confers increased insulin sensitivity in mice: A potential target for the treatment of type 2 diabetes? Smaller mice and with less insulin Article reference
Oriol Bestard, Israel Molina y Francisco Gudiol son los ganadores de los Premios de Investigación del ICS
El Instituto Catalán de la Salud (ICS) ha dado a conocer, en el marco de la 7ª Jornada de Investigación de la organización, la concesión del Premio al Investigador Joven 2015 y el Premio a la Trayectoria Investigadora a los Hospitales de la ICS. El primero ha recaído ex aequo en los investigadores Oriol Bestard […]
Antibiotic resistance is one of the major problems in the treatment of infectious diseases
The 7th ICS Research Day will address how ICS research professionals work to optimize the use of these drugs About 200 researchers from research centers linked to the organization will share how they work to counter resistance to drugs used to treat infectious diseases 400.000 deaths attributable to antimicrobial resistance in Europe by 2050
